A field guide to BPC-157The criteria
PRODUCT / CARE / COMMITMENT
Open the provider file

Provider review

CareFirst Specialty Pharmacy BPC-157 review: the outside prescription comes first

A capsule listing cannot be substituted for an injection order or a consultation bundle.

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

On this page
PROVIDER FILE / CareFirst Specialty Pharmacy

The field notes

The pharmacy price does not buy the prescriber's appointment. Will the existing prescriber send the prescription, and what will the complete fill, delivery and clinical follow-up cost?

What is on the record

  • Outside patient-specific prescription required
  • The pharmacy price does not buy the prescriber's appointment

Read the small print

  • A capsule listing cannot be substituted for an injection order or a consultation bundle.
  • Will the existing prescriber send the prescription, and what will the complete fill, delivery and clinical follow-up cost?
Open the published facts
Published payment basis
Advertised from $49.95; current prescription quote required
Preparation record
Compounded oral capsules
Care process
Outside patient-specific prescription required
Access setting
Pharmacy fill rather than a prescribing-clinic package

Arrange the prescriber before the fill

CareFirst lists compounded oral BPC-157 capsules from $49.95 and requires an outside patient-specific prescription. That makes the prescriber appointment a separate purchase and responsibility. Someone arriving without a treating clinician has not found a complete consultation package here. Put the pharmacy quote and the outside visit on separate lines in the cost planner; confirm the actual capsule quantity and delivery charge before comparing totals.

Before committing

Will the existing prescriber send the prescription, and what will the complete fill, delivery and clinical follow-up cost?

A boundary for research claims

A pharmacy listing cannot establish renal protection. In the gentamicin kidney-injury experiment, investigators studied a toxicant challenge; the result does not establish that a filled capsule prevents kidney injury in a patient.

When a urinary claim appears

Urinary-symptom claims also need a matching endpoint. In the BPC-157 stress-incontinence experiment, a surgically manipulated animal system was used to study pressure control; that does not establish that an oral capsule treats a person’s incontinence.

Another offer to put beside it

The Nava Health service review offers a useful contrast: the service page names both BPC-157 and blends while describing a wider testing process. Read its terms alongside this offer before treating the two prices as equivalent.

References & product documents

The evidence and service information used here.

  1. CareFirst Specialty Pharmacy official BPC-157 service or pricing recordCompany website

Next in the field guide

The provider file
  1. 01

    Nava Health BPC-157 review: the lab program and the product are separate

    The service page names both BPC-157 and blends while describing a wider testing process.

  2. 02

    BPC-157 in gentamicin-related kidney injury

    The experiment does not establish prevention of antibiotic toxicity in patients.

  3. 03

    BPC-157 in two female-rat continence models

    An animal pressure endpoint does not establish symptom relief or a treatment choice for people.

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review